Since KEAP1/NFE2L2/CUL3 gene mutations have not received enough attention in the clinical practice of lung adenocarcinoma, these three genes are not included in routine postoperative pathologic sample gene mutation detection in our hospital. This evidence concerns the gene CUL3 and lung adenocarcinoma.